Healthcare -
Biotechnology - NASDAQ - BM
$ 18.54
0.816 %
$ 1.34 B
Market Cap
-154.5
P/E
Price Target
Average
95.97%
Revenue Forecast
Estimate
46.23%
EBIT
Estimate
102.07%
Net Income
Estimate
57.84%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Kiniksa Pharmaceuticals, Ltd.
Wall Street analysts predict an average 1-year price target for KNSA of $36.3 , with forecasts ranging from
a
low of
$34 to a high of $40 .
KNSA Lowest Price Target
Wall Street Target
34 USD
83.39%
KNSA Average Price Target
Wall Street Target
36.3 USD
95.97%
KNSA Highest Price Target
Wall Street Target
40 USD
115.75%
REVENUE FORECAST
Revenue Forecast Chart KNSA
EBIT FORECAST
EBIT Forecast Chart KNSA
NET INCOME FORECAST
Net Income Chart KNSA